Clinton Group Inc. Buys 22,753 Shares of Agilent Technologies, Inc. (A)
Clinton Group Inc. grew its stake in Agilent Technologies, Inc. (NYSE:A) by 475.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,541 shares of the medical research company’s stock after purchasing an additional 22,753 shares during the period. Clinton Group Inc.’s holdings in Agilent Technologies were worth $1,633,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. grew its holdings in shares of Agilent Technologies by 1.2% in the 2nd quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock worth $1,387,400,000 after purchasing an additional 273,119 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Agilent Technologies by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock worth $1,310,374,000 after purchasing an additional 637,698 shares in the last quarter. FMR LLC increased its position in shares of Agilent Technologies by 3.9% during the 1st quarter. FMR LLC now owns 21,588,407 shares of the medical research company’s stock worth $1,141,379,000 after purchasing an additional 803,993 shares in the last quarter. State Street Corp increased its position in shares of Agilent Technologies by 1.0% during the 1st quarter. State Street Corp now owns 14,457,425 shares of the medical research company’s stock worth $764,348,000 after purchasing an additional 147,518 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Agilent Technologies by 45.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock worth $720,358,000 after purchasing an additional 3,779,099 shares in the last quarter.
In related news, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total value of $286,335.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Didier Hirsch sold 72,545 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 170,720 shares of company stock worth $10,795,039.
Several equities analysts recently issued reports on A shares. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Deutsche Bank AG reaffirmed a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a research note on Thursday, June 22nd. Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a report on Monday, July 10th. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $42.92 to $60.73 in a report on Wednesday, July 12th. Finally, Barclays PLC reaffirmed a “buy” rating and set a $67.00 price objective on shares of Agilent Technologies in a report on Wednesday, July 19th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $64.38.
Agilent Technologies, Inc. (A) traded up 0.80% during midday trading on Tuesday, hitting $65.39. The stock had a trading volume of 146,640 shares. The company has a market capitalization of $21.04 billion, a PE ratio of 33.72 and a beta of 1.30. The company’s 50-day moving average price is $64.03 and its 200 day moving average price is $59.15. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $66.45.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the business earned $0.49 earnings per share. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. On average, analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd will be issued a dividend of $0.132 per share. This represents a $0.53 annualized dividend and a dividend yield of 0.81%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 27.32%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.